Grant Pickering Vaxcyte, Inc. (PCVX) insider trading activity

Grant Pickering is CHIEF EXECUTIVE OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 465,301 shares of PCVX, which is worth approximately $40 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 710 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 465K

2.84% 3M change

20.57% 12M change

Total Value Held $40 Million

GRANT PICKERING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Bona fide gift	-	710 Reduced 0.15%	465,301 Common Stock
Nov 07 2024	BUY Exercise of conversion of derivative security	$76,056 $2.47 p/Share	30,792 Added 6.2%	466,011 Common Stock
Nov 01 2024	SELL Open market or private sale	$1,611,000 $107.4 p/Share	15,000 Reduced 3.33%	435,219 Common Stock
Oct 01 2024	SELL Open market or private sale	$6,280,450 $114.19 p/Share	55,000 Reduced 10.89%	450,219 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$214,000 $5.35 p/Share	40,000 Added 7.84%	470,219 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$1,505,640 $110.15 p/Share	13,669 Reduced 2.85%	465,219 Common Stock
Aug 23 2024	SELL Open market or private sale	$1,184,250 $78.95 p/Share	15,000 Reduced 3.04%	478,888 Common Stock
Aug 23 2024	BUY Exercise of conversion of derivative security	$30,449 $2.03 p/Share	15,000 Added 2.95%	493,888 Common Stock
Jul 23 2024	SELL Open market or private sale	$1,262,700 $84.18 p/Share	15,000 Reduced 3.04%	478,888 Common Stock
Jul 23 2024	BUY Exercise of conversion of derivative security	$30,449 $2.03 p/Share	15,000 Added 2.95%	493,888 Common Stock
Jun 24 2024	SELL Open market or private sale	$1,141,800 $76.12 p/Share	15,000 Reduced 3.04%	478,888 Common Stock
Jun 24 2024	BUY Exercise of conversion of derivative security	$30,449 $2.03 p/Share	15,000 Added 2.95%	493,888 Common Stock
May 23 2024	SELL Open market or private sale	$1,040,100 $69.34 p/Share	15,000 Reduced 3.04%	477,847 Common Stock
May 23 2024	BUY Exercise of conversion of derivative security	$30,449 $2.03 p/Share	15,000 Added 2.95%	492,847 Common Stock
Apr 23 2024	SELL Open market or private sale	$928,800 $61.92 p/Share	15,000 Reduced 3.04%	477,847 Common Stock
Apr 23 2024	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.95%	492,847 Common Stock
Mar 25 2024	SELL Open market or private sale	$1,007,850 $67.19 p/Share	15,000 Reduced 3.04%	477,847 Common Stock
Mar 25 2024	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.95%	492,847 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$131,950 $2.03 p/Share	65,000 Added 11.97%	477,847 Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$570,038 $71.55 p/Share	7,967 Reduced 1.89%	412,847 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	45,000 Added 9.66%	420,814 Common Stock
Feb 26 2024	SELL Open market or private sale	$2,370,900 $79.03 p/Share	30,000 Reduced 7.39%	375,814 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	$53,700 $1.79 p/Share	30,000 Added 6.88%	405,814 Common Stock
Feb 23 2024	SELL Open market or private sale	$1,146,000 $76.4 p/Share	15,000 Reduced 3.84%	375,814 Common Stock
Feb 23 2024	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 3.7%	390,814 Common Stock

Also insider at

ATHA

Athira Pharma, Inc. Healthcare

Grant Pickering

CHIEF EXECUTIVE OFFICER

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account